United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

actelion pharmaceuticals uk ltd - miglustat - capsule - 100mg

European Union - English - EMA (European Medicines Agency)

amicus therapeutics europe limited - cipaglucosidase alfa - glycogen storage disease type ii - other alimentary tract and metabolism products, - pombiliti (cipaglucosidase alfa) is a long-term enzyme replacement therapy used in combination with the enzyme stabiliser miglustat for the treatment of adults with late-onset pompe disease (acid α-glucosidase [gaa] deficiency).

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

ethnor del istmo, s.a. - miglustat - miglustat....100 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

actelion pharmaceuticals australia pty limited - miglustat -

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

janssen pharmaceutical k.k. - miglustat - white capsules, major axis: 14 mm, minor axis: 6.5 mm

Australia - English - Department of Health (Therapeutic Goods Administration)

actelion pharmaceuticals australia pty limited - miglustat -

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - eliglustat tartrate, quantity: 100 mg (equivalent: eliglustat, qty 84.4 mg) - capsule, hard - excipient ingredients: lactose monohydrate; hypromellose; microcrystalline cellulose; glycerol dibehenate; iron oxide yellow; gelatin; indigo carmine aluminium lake; titanium dioxide; mica; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - cerdelga is indicated for the long-term treatment of adult patients with gaucher disease type 1 (gd1).